Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Evaluate whether the clinical efficacy of PF-04634817 is non-inferior to ranibizumab, as measured by change from baseline in best corrected visual acuity after 12 weeks of treatment in subjects with diabetic macular edema (DME).
Inclusion criteria
- Diabetic Macular Edema (DME)